Rockeby signs HK distributor

By Melissa Trudinger
Monday, 12 January, 2004

Recently floated diagnostics company Rockeby Biomed (ASX:RBY) has signed up Asia-Pacific healthcare and pharmaceutical distributor JDH Healthcare as its exclusive distributor for its Candia5 Rapid Test kit in Hong Kong and Macau.

The unique test for vaginal candidiasis (thrush) -- a disease that affects 75 per cent of women at least once in their lifetime -- will be initially marketed there as a point of care test available from general practitioners, gynaecologists and obstetricians.

It has already been launched in several other Asia-Pacific markets including Australia, New Zealand, Singapore and Malaysia.

The Singapore- and Australia-based company listed on the ASX on December 23rd at AUD$0.20 and at the time of writing was trading at $0.245.

Related News

TGA acts on melatonin imports with infringement notices totalling $99K

Laboratory testing of several imported unregistered melatonin products has confirmed them to be...

Scientists search for cystitis pain 'off switch'

By targeting certain pain receptors in the bladder, Australian scientists believe that the...

Australia's first cases of H5 avian influenza confirmed

Positive results for H5 avian influenza (bird flu) have been confirmed in two seabirds found in...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd